Will New Treatment Options for Lupus Nephritis Be Affordable?

Clin J Am Soc Nephrol. 2022 Mar;17(3):340-341. doi: 10.2215/CJN.00690122. Epub 2022 Feb 4.

Authors

Y K Onno Teng¹, Ton J Rabelink

Affiliation

¹ Center of Expertise for Lupus-, Vasculitis-, and Complement-Mediated Systemic Disease, Department of Internal Medicine, Section of Nephrology, Leiden University Medical Center, Leiden, The Netherlands.

No abstract available

Keywords: belimumab; glomerulonephritis; lupus nephritis; voclosporin.

Publication types

Editorial
Comment

MeSH terms

Cyclosporine
Female
Humans
Immunosuppressive Agents / therapeutic use
Lupus Erythematosus, Systemic*
Lupus Nephritis* / drug therapy
Male
Mycophenolic Acid

Substances

Immunosuppressive Agents
Cyclosporine
Mycophenolic Acid